These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23640993)

  • 1. EBV DNA: a Hodgkin lymphoma biomarker?
    Meyer RM
    Blood; 2013 May; 121(18):3541-2. PubMed ID: 23640993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
    Kanakry JA; Li H; Gellert LL; Lemas MV; Hsieh WS; Hong F; Tan KL; Gascoyne RD; Gordon LI; Fisher RI; Bartlett NL; Stiff P; Cheson BD; Advani R; Miller TP; Kahl BS; Horning SJ; Ambinder RF
    Blood; 2013 May; 121(18):3547-53. PubMed ID: 23386127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sequential monitoring of plasma EBV-DNA level in a patient with EBV-positive Hodgkin lymphoma].
    Uchida E; Honma R; Igarashi A; Kurata M; Imadome K; Omoto E; Miura O; Arai A
    Rinsho Ketsueki; 2012 Jan; 53(1):87-91. PubMed ID: 22374530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma.
    Hohaus S; Santangelo R; Giachelia M; Vannata B; Massini G; Cuccaro A; Martini M; Cesarini V; Cenci T; D'Alo F; Voso MT; Fadda G; Leone G; Larocca LM
    Clin Cancer Res; 2011 May; 17(9):2885-92. PubMed ID: 21478335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment whole blood Epstein-Barr virus-DNA is a significant prognostic marker in patients with Hodgkin lymphoma.
    Park JH; Yoon DH; Kim S; Park JS; Park CS; Sung H; Lee SW; Huh J; Suh C
    Ann Hematol; 2016 Apr; 95(5):801-8. PubMed ID: 26883027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Epstein Barr virus (EBV) DNA as a biomarker for EBV associated Hodgkin lymphoma.
    Dinand V; Sachdeva A; Datta S; Bhalla S; Kalra M; Wattal C; Radhakrishnan N
    Indian Pediatr; 2015 Aug; 52(8):681-5. PubMed ID: 26388626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria.
    Habeeb R; Al Hafar L; Monem F
    J Infect Dev Ctries; 2021 Dec; 15(12):1917-1922. PubMed ID: 35044951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
    Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern combined antiretroviral therapy era.
    Lupo J; Germi R; Lancar R; Algarte-Genin M; Hendel-Chavez H; Taoufik Y; Mounier N; Partisani M; Bonnet F; Meyohas MC; Marchou B; Semanova T; Prevot S; Costagliola D; Morand P; Besson C
    AIDS; 2019 May; 33(6):993-1000. PubMed ID: 30946153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
    Machado AS; Da Silva Robaina MC; Magalhães De Rezende LM; Apa AG; Amoêdo ND; Bacchi CE; Klumb CE
    Leuk Lymphoma; 2010 Jun; 51(6):1020-7. PubMed ID: 20470219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein Barr virus-positive mucocutaneous ulcer of the colon associated Hodgkin lymphoma in Crohn's disease.
    Moran NR; Webster B; Lee KM; Trotman J; Kwan YL; Napoli J; Leong RW
    World J Gastroenterol; 2015 May; 21(19):6072-6. PubMed ID: 26019475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma.
    Gandhi MK; Lambley E; Burrows J; Dua U; Elliott S; Shaw PJ; Prince HM; Wolf M; Clarke K; Underhill C; Mills T; Mollee P; Gill D; Marlton P; Seymour JF; Khanna R
    Clin Cancer Res; 2006 Jan; 12(2):460-4. PubMed ID: 16428487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Levels of Plasma Epstein Barr Virus DNA Identify a Poor-Risk Subset of Patients With Advanced Stage Cutaneous T-Cell Lymphoma.
    Haverkos BM; Gru AA; Geyer SM; Bingman AK; Hemminger JA; Mishra A; Wong HK; Pancholi P; Freud AG; Caligiuri MA; Baiocchi RA; Porcu P
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl(Suppl):S181-S190.e4. PubMed ID: 27521316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
    Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
    APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The prognostic significance of plasma Epstein-Barr virus DNA in patients with diffuse large B cell lymphoma].
    An N; Xie YP; Xu Y; Shi PF; Qian SX
    Zhonghua Nei Ke Za Zhi; 2017 Nov; 56(11):839-841. PubMed ID: 29136714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Epstein-Barr virus DNA is helpful for evaluation of chronic active Epstein-Barr virus infection.
    Sakamoto Y; Mariya Y; Kubo K
    Tohoku J Exp Med; 2012 Aug; 227(4):307-11. PubMed ID: 22850617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of Epstein-Barr virus DNA detection in pretreatment serum in diffuse large B-cell lymphoma.
    Okamoto A; Yanada M; Miura H; Inaguma Y; Tokuda M; Morishima S; Kanie T; Yamamoto Y; Mizuta S; Akatsuka Y; Yoshikawa T; Mizoguchi Y; Nakamura S; Okamoto M; Emi N
    Cancer Sci; 2015 Nov; 106(11):1576-81. PubMed ID: 26353084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment whole blood Epstein-Barr virus DNA predicts prognosis in Hodgkin lymphoma.
    Qin JQ; Yin H; Wu JZ; Chen RZ; Xia Y; Wang L; Zhu HY; Fan L; Li JY; Liang JH; Xu W
    Leuk Res; 2021 Aug; 107():106607. PubMed ID: 33957372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitation of whole blood Epstein-Barr virus DNA is useful for assessing treatment response in patients with non-Hodgkin's lymphoma.
    Jo SA; Hwang SH; Kim SY; Shin HJ; Chung JS; Sol MY; Chang CL; Lee EY
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e106-13. PubMed ID: 19522857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection.
    Chan KH; Ng MH; Seto WH; Peiris JS
    J Clin Microbiol; 2001 Nov; 39(11):4152-4. PubMed ID: 11682546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.